• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIK2通过PI3K/AKT/mTOR信号通路促进乳腺癌细胞有氧糖酵解诱导的顺铂耐药。

SIK2 Promotes Cisplatin Resistance Induced by Aerobic Glycolysis in Breast Cancer Cells through PI3K/AKT/mTOR Signaling Pathway.

作者信息

Zong Shoukai, Dai Wei, Fang Wencheng, Guo Xiangting, Wang Kai

机构信息

People's Hospital of Rizhao, Rizhao, China.

出版信息

Biosci Rep. 2020 May 27. doi: 10.1042/BSR20201302.

DOI:10.1042/BSR20201302
PMID:32458975
Abstract

This study aimed to investigate the effect of SIK2 on cisplatin resistance induced by aerobic glycolysis in breast cancer cells and its potential mechanism. qRt-PCR and Western blot were used to detect SIK2 mRNA and protein levels, and cisplatin (DDP) resistant cell lines of breast cancer cells were established. Viability was measured and evaluated via CCK-8, cell invasion capability was evaluated via Transwell, and apoptosis rate was assessed via Flow cytometry. The glycolysis level was evaluated by measuring glucose consumption and lactic acid production. The protein levels of p-PI3K, p- protein kinase B (Akt) and p-mTOR were determined by western blot. SIK2 was highly expressed in breast cancer tissues and cells compared with adjacent tissues and normal human breast epithelial cells, and it had higher diagnostic value for breast cancer. Silencing SIK2 expression can inhibit proliferation and invasion of breast cancer cells and induce their apoptosis. In addition, SIK2 knockdown inhibits glycolysis, reverses the resistance of drug-resistant cells to cisplatin, and inhibits PI3K/AKT/mTOR signaling pathway. When LY294002 was used to inhibit PI3K/AKT/mTOR signaling pathway, the effect of pcDNA3.1-SIK2 on aerobic glycolysis of breast cancer cells could be reversed. SIK2 can promote cisplatin resistance caused by aerobic glycolysis of breast cancer cells through PI3K/AKT/mTOR signaling pathway, which may be a new target to improve cisplatin resistance of breast cancer cells.

摘要

本研究旨在探讨盐诱导激酶2(SIK2)对乳腺癌细胞有氧糖酵解诱导的顺铂耐药性的影响及其潜在机制。采用qRt-PCR和蛋白质免疫印迹法检测SIK2 mRNA和蛋白水平,并建立乳腺癌细胞的顺铂(DDP)耐药细胞系。通过CCK-8法检测并评估细胞活力,通过Transwell法评估细胞侵袭能力,通过流式细胞术评估细胞凋亡率。通过测量葡萄糖消耗和乳酸生成来评估糖酵解水平。通过蛋白质免疫印迹法测定磷酸化磷脂酰肌醇-3激酶(p-PI3K)、磷酸化蛋白激酶B(Akt)和磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)的蛋白水平。与癌旁组织和正常人乳腺上皮细胞相比,SIK2在乳腺癌组织和细胞中高表达,对乳腺癌具有较高的诊断价值。沉默SIK2表达可抑制乳腺癌细胞的增殖和侵袭并诱导其凋亡。此外,敲低SIK2可抑制糖酵解,逆转耐药细胞对顺铂的耐药性,并抑制PI3K/AKT/mTOR信号通路。当使用LY294002抑制PI3K/AKT/mTOR信号通路时,pcDNA3.1-SIK2对乳腺癌细胞有氧糖酵解的影响可被逆转。SIK2可通过PI3K/AKT/mTOR信号通路促进乳腺癌细胞有氧糖酵解引起的顺铂耐药性,这可能是提高乳腺癌细胞顺铂耐药性的新靶点。

相似文献

1
SIK2 Promotes Cisplatin Resistance Induced by Aerobic Glycolysis in Breast Cancer Cells through PI3K/AKT/mTOR Signaling Pathway.SIK2通过PI3K/AKT/mTOR信号通路促进乳腺癌细胞有氧糖酵解诱导的顺铂耐药。
Biosci Rep. 2020 May 27. doi: 10.1042/BSR20201302.
2
Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.敲低 KLF5 通过抑制 PI3K/Akt/mTOR 通路的失活来调节 HIF-1α 依赖性糖酵解,从而抑制 NSCLC 细胞缺氧诱导对顺铂的耐药性。
J Transl Med. 2018 Jun 14;16(1):164. doi: 10.1186/s12967-018-1543-2.
3
Knockdown of FOXO6 Inhibits Glycolysis and Reduces Cell Resistance to Paclitaxel in HCC Cells via PI3K/Akt Signaling Pathway.敲低FOXO6通过PI3K/Akt信号通路抑制肝癌细胞的糖酵解并降低其对紫杉醇的耐药性。
Onco Targets Ther. 2020 Feb 19;13:1545-1556. doi: 10.2147/OTT.S233031. eCollection 2020.
4
ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.ALC1 敲低通过 PI3K/Akt 通路抑制糖酵解增强食管鳞癌细胞对顺铂的细胞毒性。
Life Sci. 2019 Sep 1;232:116679. doi: 10.1016/j.lfs.2019.116679. Epub 2019 Jul 21.
5
Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.沉默长链非编码RNA ROR通过抑制PI3K/Akt/mTOR信号通路提高非小细胞肺癌对顺铂的敏感性。
Tumour Biol. 2017 May;39(5):1010428317697568. doi: 10.1177/1010428317697568.
6
DICER activates autophagy and promotes cisplatin resistance in non-small cell lung cancer by binding with let-7i-5p.DICER 通过与 let-7i-5p 结合激活自噬并促进非小细胞肺癌对顺铂的耐药性。
Acta Histochem. 2021 Oct;123(7):151788. doi: 10.1016/j.acthis.2021.151788. Epub 2021 Sep 17.
7
Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.内质网应激通过调控PI3K/AKT/mTOR信号通路对人乳腺癌细胞自噬、凋亡及化疗耐药性的影响
Tumour Biol. 2017 May;39(5):1010428317697562. doi: 10.1177/1010428317697562.
8
LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway.LDLR 通过 PI3K/AKT/mTOR 信号通路促进卵巢癌中顺铂耐药相关的自噬。
Kaohsiung J Med Sci. 2023 Aug;39(8):779-788. doi: 10.1002/kjm2.12696. Epub 2023 May 23.
9
KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer PI3K/AKT/mTOR Signaling Pathway.驱动蛋白家族成员C3(KIFC3)通过PI3K/AKT/mTOR信号通路促进结直肠癌的增殖、迁移和侵袭。
Front Genet. 2022 Jun 22;13:848926. doi: 10.3389/fgene.2022.848926. eCollection 2022.
10
Down-Regulating the Expression of miRNA-21 Inhibits the Glucose Metabolism of A549/DDP Cells and Promotes Cell Death Through the PI3K/AKT/mTOR/HIF-1α Pathway.下调miRNA-21的表达可抑制A549/DDP细胞的葡萄糖代谢,并通过PI3K/AKT/mTOR/HIF-1α途径促进细胞死亡。
Front Oncol. 2021 May 11;11:653596. doi: 10.3389/fonc.2021.653596. eCollection 2021.

引用本文的文献

1
Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers.小细胞外囊泡在癌症代谢重编程和耐药性中的新作用
Cancer Drug Resist. 2024 Sep 27;7:38. doi: 10.20517/cdr.2024.81. eCollection 2024.
2
Molecular Mechanism Analysis of the Effect of Hederagenin Combined with L-OHP on Chemosensitivity of AGS/L-OHP Based on Network Pharmacology.基于网络药理学的常春藤皂苷元联合奥沙利铂对AGS/L-OHP细胞化疗敏感性影响的分子机制分析
Curr Comput Aided Drug Des. 2024 Jan 11. doi: 10.2174/0115734099270389240104050955.
3
RBM8A Depletion Decreases the Cisplatin Resistance and Represses the Proliferation and Metastasis of Breast Cancer Cells via AKT/mTOR Pathway.
RBM8A 耗竭通过 AKT/mTOR 通路降低顺铂耐药性并抑制乳腺癌细胞的增殖和转移。
Breast J. 2022 Aug 28;2022:4576789. doi: 10.1155/2022/4576789. eCollection 2022.
4
LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway.LINC00092 通过丙酮酸羧化酶介导的 AKT/mTOR 通路调节乳腺癌细胞的氧化应激和糖酵解。
Oxid Med Cell Longev. 2022 Jun 28;2022:5215748. doi: 10.1155/2022/5215748. eCollection 2022.
5
Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR-200c/SIK2/PI3K/Akt axis.circPTK2 的过表达通过 miR-200c/SIK2/PI3K/Akt 轴抑制非酒精性脂肪性肝病的进展。
Kaohsiung J Med Sci. 2022 Sep;38(9):869-878. doi: 10.1002/kjm2.12568. Epub 2022 Jul 6.
6
Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis.环状 RNA UBAP2 通过 microRNA-300/抗沉默功能 1B 组蛋白伴侣/PI3K/AKT/mTOR 轴促进三阴性乳腺癌的顺铂耐药性。
Bioengineered. 2022 Mar;13(3):7197-7208. doi: 10.1080/21655979.2022.2036894.
7
Role of salt‑inducible kinase 2 in the malignant behavior and glycolysis of colorectal cancer cells.盐诱导激酶 2 在结直肠癌细胞恶性行为和糖酵解中的作用。
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12460. Epub 2021 Sep 24.
8
Glycolysis-induced drug resistance in tumors-A response to danger signals?肿瘤糖酵解诱导的耐药性——对危险信号的反应?
Neoplasia. 2021 Feb;23(2):234-245. doi: 10.1016/j.neo.2020.12.009. Epub 2021 Jan 6.